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Vaccination has saved many lives and prevented needless suffering from disease, but it is not always effec-
tive. Immune responses are a highly ‘‘personalized’’ aspect of an individual’s biology, as they are subject to
germline genetic influences but are embodied in cell populations that continuously sample the environment.
Additionally, immunity is shaped bymemory of prior infectious diseases and other antigenic exposures. Here,
we review examples of recent technical advances and insights into human vaccine responses that are helping
to define the features associated with successful vaccination and that may enable a more predictive vacci-
nology in the future.Vaccination has been one of the most beneficial, enduring, and
inexpensive medical technologies in human history. The past
four decades of molecular immunology research have revealed
major immune system mechanisms, such as the innate immune
cells and receptors that detect generic pathogen-associated
molecular patterns (PAMPs), and the adaptive responses and
cell-specific antigen receptors of B cells and T cells that encode
the memory of prior pathogen exposures. However, knowledge
of these components of effective immune responses has often
been more useful in hindsight for explaining features of success-
ful human vaccines, rather than providing a clear prescription for
optimal design of new vaccines against challenging pathogens
such as the human immunodeficiency virus (HIV), Mycobacte-
rium tuberculosis, the Plasmodium organisms that cause ma-
laria, or even influenza viruses that vary by antigenic shift and
drift in successive years. Indeed, immune responses are likely
to be one of the most ‘‘personalized’’ aspects of an individual’s
biology, as they are subject to germline genetic influences, but
are particularly responsive to the environment, and are shaped
by immunological memory of prior infectious diseases and other
antigenic exposures.
Several new high-throughput technologies now promise to
enable comprehensive tracking of all immunological cell sub-
sets, extending even to the level of the individual clones of B cells
and T cells that carry out adaptive responses. This fine-grained
phenotyping of immune system activities can compensate, in
part, for the ethical and practical limitations of experiments using
human blood samples compared to work in animal models
where genetic manipulation of the host is possible and solid
lymphoid tissues can be readily analyzed. Improvements in the
toolkit for human immunological studies are ongoing and are of
critical importance, as the results of human studies are more
likely to be of direct medical relevance and to be translatable
to diagnostic or therapeutic use.
Here, we survey selected examples of these recent technical
advances and insights into human vaccine responses that are
helping to define the features associated with effective vaccina-
tion and that could be used in the future to predict responses to
new vaccines. Research on germline and somatic genetic influ-
ences in vaccination, greatly improved methods for single-cell
studies, and methods for deconvoluting the complex mixture
of antibody species in serum have begun to be correlated withtraditional serological titer readouts of vaccination. In addition,
work on gene expression patterns early in vaccination, the activ-
ity of innate immune pathways, the effects of adjuvants, and the
role of less-studied factors such as the microbiome on immune
responses is allowing researchers tomap the biological contexts
shaping lymphocyte responses. We anticipate that such studies
will enable better understanding of clinical and demographic fac-
tors previously noted to alter vaccine responses, such as age,
sex, stress, and nutritional status, as well as the unique contribu-
tions derived from an individual’s genome and their personal his-
tory of prior infections, vaccinations, and antigenic exposures.
These key elements that could contribute to a more predictive
human immunology are shown in Figure 1.
Germline Genetics of Human Immunity
Human genetic diversity is a major candidate potentially contrib-
uting to variability in vaccine responses. If germline genetics
could be helpful in predicting an individual’s response to a partic-
ular vaccine, or even to all vaccinations, then identical twins
should show more similar immune responses than dizygotic
twins or unrelated individuals, and genetic variants should be
able to be correlated with the levels or functional activities of
immunological cell types in the body. Prior studies of monozy-
gotic and dizygotic twins have reported some heritability of
vaccine antibody responses, particularly in infants, most dramat-
ically in the case of Hepatitis B (HBV) vaccination, where serolog-
ical responses in infants indicated 77% and 91% heritability in
two studies, and 61% heritability in a study of adult twins (Ho¨hler
et al., 2002; Newport et al., 2004; Yan et al., 2013). Other infant
vaccine responses have also been reported to have significant
heritability, albeit to a lesser degree than HBV (Newport et al.,
2004). Extending the examination of genetic influences on vac-
cine responses, a very recent study ofmono- and dizygotic twins
measured 204 different immunological parameters, including
frequencies of 95 different cell populations, cellular responses
to cytokine stimulation, and serum levels of 51 different cyto-
kines, chemokines, and growth factors, as well as responses
to seasonal influenza vaccination (Brodin et al., 2015). Although
levels of some cell subsets have strong evidence of heritability,
including naive T cells, CD27 (tumor necrosis factor receptor su-
perfamily member 7)-expressing T cells, and central memory
CD4+ T cells, most appear to be dominated by non-heritableCell Host & Microbe 17, March 11, 2015 ª2015 Elsevier Inc. 301
Figure 1. Inputs and Outputs that Could
Contribute to Better Prediction of Human
Immune System Behavior
A simplified view of the human immune system is
depicted, first indicating the role of the individual’s
genome in initially shaping the levels and behavior
of some immune cell populations early in life.
Repeated exposures to pathogens, environmental
antigens, and vaccinations trigger immunological
responses that alter the clonal populations and
phenotypes of B cells and T cells, establishing
pools ofmemory cells and effector cell populations
such as plasma cells secreting antibodies, and a
variety of effector and regulatory T cell pop-
ulations. Not shown but also important are natural
killer cells and the many other cell populations
that contribute to host defenses apart from those
of adaptive immunity. The responses to prior ex-
posures alter future immune system reactions.
Both established immunological assays and
some powerful new technological approaches
described in this Minireview can be used to cap-
ture longitudinal information about the state of
the immune system. Such data sets would form
the starting point for attempting to predict the
response of an individual human subject to future
immunological exposures.
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show strong heritability, including IL-12p40, G-CSF, GM-CSF,
IFN-alpha, IL-6, and IL-7, but many others, including IL-10, do
not. Phosphorylation of the transcription factor STAT-5 in
T cells following stimulation by homeostatic cytokines IL-2 and
IL-7 has high heritability, in contrast to phosphorylation of
STAT-1 in response to interferon, or phosphorylation of STAT-
3 in response to IL-6, IL-21, or IL-10. Comparing monozygotic
twins younger than 20 years of age to those older than 60 years,
the investigators highlighted immune parameters with high initial
heritability that declines with increasing age, such as the levels of
regulatory T cells, and serum levels of the chemokine CXCL10,
among other examples (Brodin et al., 2015). Notably, serum titer
responses to influenza vaccination in 2009–2011 in the predom-
inantly adult twins in the study showed no significant contribution
from heritable factors, arguing that prior vaccination and infec-
tions, as well as other environmental influences, determined
the vaccine responses (Brodin et al., 2015). Infection with
cytomegalovirus (CMV) was identified as a particularly strong
environmental influence on many immunological parameters in
monozygotic twins discordant for CMV (Brodin et al., 2015).
A complementary approach to twin studies has been geno-
type-phenotype correlation in large human cohorts, pairing
genome-wide analysis of sequence variants with highly detailed
immunological phenotyping, such as measurement of the levels
of leukocyte cell subsets. Orru` and coauthors used flow cytom-
etry to measure the levels of 95 different cell subsets in the
blood of 1,629 Sardinian subjects and then attempted to identify
genetic associations with cell phenotypic traits, using single-302 Cell Host & Microbe 17, March 11, 2015 ª2015 Elsevier Inc.nucleotide polymorphism array genotyp-
ing and low-depth (four-fold coverage)
genome sequence data (Orru` et al.,
2013). Significant genetic associations
were identified for 132 cellular traits;
the proportion of explained heritabilityranged from 4% to 90%, with 35 traits having greater than
50% of their heritability explained (Orru` et al., 2013). Variants
at or near the genes for CD39 (nucleotide triphosphate diphos-
phohydrolase-1), CD25 (the alpha chain of the IL2 receptor pre-
sent on activated T and B cells), and CD8 (T cell co-receptor for
class I MHC) were associated with levels of T cell subsets ex-
pressing these markers, while variants in the TNFSF13B gene
encoding the growth factor B cell-activating factor of the TNF
family (BAFF) were correlated with the levels of B cells in the
blood.
Other more targeted studies of genetic linkage to vaccine re-
sponses have revealed important roles for many genes, such
as the human leukocyte antigen (HLA) genes that have a perva-
sive influence on immune system activities. HLA polymorphisms
have been correlated with low antibody response to measles
vaccination in individuals homozygous at one or more HLA loci
(St Sauver et al., 2002) or carrying specific alleles such as
HLA-DRB1*03 and DQA1*0201 (Poland et al., 2001). Other
HLA alleles (HLA-B*44, DRB1*01, DRB1*08, and DQA1*0104)
have been observed to confer very high seropositivity following
measles-mumps-rubella (MMR) vaccination (Ovsyannikova
et al., 2004). Single-nucleotide polymorphisms (SNPs) in other
genes such as cellular receptors exploited by pathogens for en-
try (SLAM and CD46 for measles) can also impact humoral re-
sponses, with significant additive effects for genetic variants in
these receptors resulting in decreased measles antibodies
following MMR vaccination (Dhiman et al., 2007). Genetic varia-
tion among cytokines and their receptors have also been linked
to disparate response to HBV vaccination. Among 53 candidate
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70 subjects, two were associated with significantly different
response to HBV vaccination between responders and non-
responders: an IL-13 allele that increased the risk of non-
response, and an IL-4RA allele that was associated with a
protective immune response (Chen et al., 2011).
Taken together, the current data indicate that germline genetic
influences on the immune system are strongest in infancy and
early life and can play a major role in vaccine responses. How-
ever, while some cell subsets and phenotypes continue to
show high heritability throughout life, most immune system fea-
tures in adults have been strongly influenced by the environment,
including prior immunological exposures and infections. Thus,
efforts to predict future vaccine responses will require measuring
and understanding the effects of prior environmental influences
on an individual’s immune system.
Somatic Genetics of Immunoglobulin and T Cell
Receptor Rearrangements
Until very recently, the diversity and sheer number of antibody
and T cell receptor (TCR) gene rearrangements in the human
body had greatly exceeded the capacity of available measure-
ment techniques. These rearrangements involve the combinato-
rial joining of V, (D), and J gene segments, with variable degrees
of exonuclease digestion of segment ends, and strings of
random nucleotide insertions at each junction to create diversity
in the antibody and TCR recognition of antigens. Beginning in
2005, improved DNA sequencing methods brought to immu-
nology research the same enormous impact that they have
had on all aspects of human genetics. Analysis of the somatic
genetic rearrangements that encode immunoglobulins (Igs)
and TCRs is no longer limited to tens or hundreds of sequences,
but can assess receptor rearrangements frommillions of distinct
B cells or T cells in an individual. It has become feasible to
ask whether human B cell or T cell receptor repertoires can pre-
dict individual responses to vaccination events. Despite the
randomness inherent in Ig and TCR generation, Ig repertoire
sequencing in identical twin pairs indicates that gene segment
rearrangement frequencies and repertoire features are substan-
tially influenced by the germline genome (Glanville et al., 2011;
Wang et al., 2015). In addition to genetic influences on antibody
receptor repertoire formation, the levels of somatic mutation
accumulated in antigen-experienced B cells are also more
similar in identical twin pair members (Wang et al., 2015).
Despite these global repertoire similarities, a recent study of
the individual responses of four adult monozygous twin pairs
to Varicella zoster virus vaccination showed no identical vac-
cine-stimulated antibody clones between twins, suggesting
that the high diversity of individual repertoires, together with sto-
chastic events during a single vaccination episode, leads to the
selection of predominantly distinct sets of responding clones
(Wang et al., 2015).
In contrast, other recent studies of B cell repertoires in unre-
lated individuals indicate that there are some significant, pre-
dictable features in the kinds of antibodies stimulated by
many vaccines or pathogens. In prior research using Sanger
sequencing, it was difficult to compare the degree of similarity
between the antibody gene rearrangements expressed by vac-
cine-stimulated B cells in different humans exposed to thesame antigens. With notable exceptions, such as the response
to Haemophilus influenzae Group b (Hib), which features stereo-
typed antibody gene rearrangements, and very rare examples
of antibody gene rearrangements identified in flu vaccine re-
sponses or HIV-infected patients, the data indicated that each
person’s immune response was unique and unpredictable. To
some extent, this conclusion was expected, as selective pres-
sures acting on pathogens would discourage expression of
epitopes easily targeted by common human antibody paratopes.
With deep-sequencing data, however, it has become clear
that similar or ‘‘convergent’’ antibody gene rearrangements in
different individuals responding to the same antigenic stimuli
can be detected. B cell responses to Dengue virus include
many antibody gene rearrangements containing similar se-
quences within the complementarity-determining region 3
(CDR3) that usually directly binds antigen, stimulated in different
individuals during acute primary or secondary infection (Para-
meswaran et al., 2013). Whether these highly similar antibodies
are in fact protective or whether they may be involved in the
more severe symptoms seen in secondary Dengue infection re-
mains to be determined. Similarly, tracking of B cell clones
following pandemic single-antigen H1N1 vaccination revealed
a strong clonal signature dominated by antibodies using the
IGHV3-7 V gene and sharing highly similar CDR3 sequences in
different humans. Monoclonal antibodies of the convergent
Ig can inhibit the activity of the influenza glycoprotein,
hemagglutinin, expressed by H1N1 and other influenza strains
(Jackson et al., 2014). Convergent or ‘‘public’’ antibody heavy
chain responses in different humans have also been detected
using deep sequencing of antibody repertoires in subjects vacci-
nated for bacterial tetanus toxoid and Hib capsular polysaccha-
ride antigens (Tru¨ck et al., 2015). Notably, the frequency of
recognizable Hib vaccine-specific antibody heavy chain se-
quences in patient repertoires was correlated with serum protein
antibody concentration and avidity, suggesting that some
convergent antibody sequences may be useful predictors of
the degree of immune protection conferred by the vaccine (Tru¨ck
et al., 2015).
Apart from providing a means for identifying similar antibody
rearrangements in different individuals, deep sequencing of Ig
gene rearrangements from peripheral blood before and following
vaccination also permits informative tracking of vaccine-stimu-
lated B cell clonal lineages (Jackson et al., 2014; Jiang et al.,
2013). Sequencing of the genomic DNA encoding functional anti-
body VDJ rearrangements, which are present as a single chro-
mosomal locus per B cell, can be used to quantify clonally
expanded B cell lineages at day 7 post-vaccination, a measure
that correlates with whether or not an individual will show serum
antibody seroconversion measured one month after vaccination
(Jackson et al., 2014). Comparison of expanded clones identified
from Ig repertoire sequencing with single-cell analysis and
monoclonal antibody production from plasmablasts confirms
that the expanded clonal signature derives in part from vaccine
antigen-specific plasmablasts, but also contains other clones
likely present in expanded memory cell populations (Jackson
et al., 2014). Sequence identification of antibody isotype sub-
classes expressed by vaccine-responsive B cells has revealed
an increased IgA response following live attenuated influenza
vaccination (LAIV), in contrast to the increased IgG followingCell Host & Microbe 17, March 11, 2015 ª2015 Elsevier Inc. 303
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2013).
Single-Cell Analyses
A full description of each cell in a human immune system would
be the ideal starting point for attempts to predict future behavior
of the system. This remains a lofty and not yet attained goal, but
single-cell methods, ranging from fluorescence-based flow cy-
tometry to groundbreaking work performed in the past two de-
cades amplifying, expressing, and characterizing monoclonal
antibodies from single B cells, have been the keys to many
fundamental insights in human vaccine research. A new genera-
tion of evenmore powerful single-cell technologies has emerged
in initial publications, promising to capture richer and more com-
plete data describing immune cells and their functions. Prior sin-
gle-cell monoclonal antibody studies have primarily focused on
characterizing antibodies expressed by plasmablasts in the
blood following vaccination, antigen-specific B cells cultured
and detected by screening for specific antibodies in culture su-
pernatants, or B cells sorted by direct antigen binding. The
many fruits of this research have included the detection of
extremely long-lived clones of memory B cells, such as B cells
recognizing the 1918 pandemic influenza strain in the very
elderly; the discovery of B cells expressing antibodies that can
neutralize multiple subtypes of viruses such as influenza, or
even several different kinds of viruses; delineation of the selec-
tion steps that help to remove B cells expressing autoreactive
antibodies from peripheral repertoires; and better understanding
of the dominant epitopes commonly recognized in vaccine re-
sponses, and the molecularly defined antibody species that
together account for serological reactivity patterns (Corti et al.,
2013, 2010; Traggiai et al., 2004;Wardemann et al., 2003;Wram-
mert et al., 2008; Xu et al., 2010; Yu et al., 2008). The laborious
nature of these experiments typically limited the number of cells
characterized to hundreds, but methods for high-throughput
sequencing of paired heavy and light chains of antibodies from
many thousands of single cells may facilitate scaled-up versions
of these analyses (DeKosky et al., 2013, 2015). In addition, pair-
ing deep sequencing of antibody genes from bulk B cell reper-
toires, with single-cell antibody isolation from clones of interest
now offers an efficient approach to identify additional members
of a clonal lineage and evaluate the maturation patterns of anti-
body somatic mutation leading to viral neutralization (Liao et al.,
2013).
Flow cytometry using time-of-flight mass spectrometry
(CyTOF) is a powerful single-cell methodology beginning to
have a major impact in human immunology research. Compared
to fluorescence flow cytometry, CyTOF canmeasure manymore
cell-surface or intracellular markers in a single experiment, using
reagent antibodies coupled to rare earth atoms and other
isotope labels with distinct mass and without the spectral over-
lap of fluorescent labels. Exciting applications of this work
include the ability to detect antigen-specific T cells to a large
number of viral peptide antigens using mass-labeled pepti-
de:MHC tetramers, together with extensive T cell phenotyping
panels (Newell et al., 2012). Another approach to gathering
high-dimensional data sets with single-cell resolution uses con-
ventional flow cytometry to sort thousands of single T cells into
wells of microtiter plates, so that single-cell PCR amplicon li-304 Cell Host & Microbe 17, March 11, 2015 ª2015 Elsevier Inc.braries for a panel of phenotypic marker genes, including T cell
receptor gene rearrangements, can be generated from cDNA
in each well. High-throughput DNA sequencing is used to count
and characterize the amplicons from each well to give single-cell
antigen receptor and transcriptional phenotype data (Han et al.,
2014). This approach is likely to be widely used in vaccine
studies in the near future. Another recent technological innova-
tion with immediate applicability to human vaccinology is the
use of yeast display libraries ofMHCmolecules with partially ran-
domized peptides, to identify the peptide ligands for T cell recep-
tors identified in human samples (Birnbaum et al., 2014). This
approachmay greatly enhance the scope for identification of an-
tigen-specific T cells in human immune responses, as the ligands
for TCRs may be identified retroactively in in vitro experiments,
rather than depending on designed T cell sorting experiments
for each antigen. While the new single-cell methods summarized
here have not yet been applied to predicting future responses of
an individual human subject, by increasing the ability to identify
and quantify antigen-specific B cell or T cell clones, as well as
new phenotypic subsets of immune cells, they should provide
valuable data for the development of predictive models.
Improved Serological Analyses
In vaccination for frequently encountered pathogens such as
influenza virus, antibodies elicited by an individual’s past expo-
sures appear to have a strong influence on new responses. For
many years the hypothesis of ‘‘original antigenic sin’’ (impair-
ment of immune responses to new antigens due to the restimu-
lation of memory B cells recognizing previously encountered
related antigens) has been a theoretical concern in vaccine stra-
tegies, but the real-life impact on human vaccine responses has
been unclear. A recent study by Fonville et al. presents a system-
atic method for assessing and summarizing serum antibody
titers toward different viral antigenic variants in response to influ-
enza vaccination or infection (Fonville et al., 2014). The re-
searchers defined the antigenic relationships between 81
H3N2 influenza strains isolated over 43 years bymeasuring hem-
agglutinin inhibition (HI) assay titers for each antigen using a
panel of sera obtained from ferrets infected with single viral
strains. Similarities in HI results were used to cluster strains
that were antigenically related, and then HI titers of human
sera were determined for each of the viral strains, to obtain an
‘‘antibody landscape’’ for each serum sample. Antibody land-
scapes in a cohort of Vietnamese subjects who had not been
vaccinated were stable from year to year and were specific to
each individual, showing highest titers to viral strains circulating
when the individual was approximately 6 years of age and was
first infected. When individuals were subsequently infected
with different strains of influenza, titers to older viral variants
were significantly boosted, but not to the same extent as titers
to recent strains more antigenically related to the infecting virus,
contrary to the predictions of the ‘‘original antigenic sin’’ hypoth-
esis. In another cohort, retrospective study of influenza antibody
landscapes following vaccination with a previously encountered
viral strain, compared to a more novel strain, indicated the more
novel vaccine strain stimulated both ‘‘back-boosting’’ of titers to
earlier viral clusters, as well as raising titers to more recent viral
clusters. Surprisingly, ‘‘back-boosting’’ by the more novel strain
was similar to the effects of vaccination with the previously
Cell Host & Microbe
Minireviewencountered strain, suggesting that there was greater benefit
from using the more novel variant. The approach to in-depth
serological phenotyping of human subjects presented by these
authors will likely be an important addition to any future system-
atic studies of human vaccine responses, particularly for viruses
such as influenza where extensive historical strain data are
available.
Gene Expression Signatures of Vaccine Responses
Another important and mature experimental approach to under-
standing vaccine responses in humans has been gene expres-
sion profiling of peripheral blood leukocytes, often appearing
under the banner of ‘‘systems immunology.’’ A pioneering study
of the early transcriptional responses to the highly effective yel-
low fever virus vaccine indicated that gene transcript levels in
the initial days after vaccination could be used to predict the
magnitude of CD8+ T cell responses, as well as antibody re-
sponses (Querec et al., 2009). Similarly, early transcriptional re-
sponses following trivalent inactivated influenza vaccination
were predictive of antibody titer stimulation (Nakaya et al.,
2011). Some of the gene expression signatures correlated with
these outcomes were consistent between the different vaccines,
such as increased expression of TNFRS17, encoding the BCMA
receptor for the B cell growth factor BAFF implicated in plasma
cell differentiation, as a predictor of antibody titers. More recent
work has extended these results to compare the transcriptional
responses to vaccination with meningococcal polysaccharides,
or polysaccharide conjugates with diphtheria toxoid, to prior
data from yellow fever, TIV, and LAIV (Li et al., 2014). Expression
signatures for groups of genes associated with type I interferon
were enriched in the primary response to the live attenuated
yellow fever vaccine, while responses to the meningococcal
carbohydrate antigens correlated with expression of gene
modules associated with dendritic cells and complement activa-
tion. Finally, gene modules associated with B cell receptor
(BCR) signaling and plasma cells were the prominent features
of TIV vaccine responses and the response to the diphtheria
toxoid component of conjugatedmeningococcal vaccine. These
results indicated that the different vaccines trigger distinct sets of
immunological events in the recipient, correlated with the longer-
termoutcomesof vaccination. It should be noted that the focusof
these studies was not to predict vaccine responses from gene
expression in samples taken prior to vaccination.
Insights into Innate Immune Effects on Vaccine
Responses: Adjuvants and Microbiomes
If vaccines were universally effective, prediction of individual
responses would be unnecessary. Efforts to improve vaccine
efficacy have led to the use of adjuvants that increase immune
responses to pathogen-specific antigens. This is a large field
of research, and space constraints prevent us from addressing
it in detail here, but an example can be seen in the use of oil-
in-water adjuvants such as MF59 to improve influenza vaccine
responses compared to vaccination without adjuvant or with
alum. Even at lower antigen concentrations, MF59 adjuvant in-
duces higher rates of seroconversion, broader antibody re-
sponses providing cross-clade protection, increased long-term
B cell memory, and targeting of different epitopes (Khurana
et al., 2010). Studies of the mechanisms for adjuvant activityhave revealed that alum acts largely through the activation of
TLRs, and there has been increasing interest in other TLR ago-
nists as potential enhancers of vaccine response. In non-human
primates, TLR agonists give rise to distinct gene expression sig-
natures in early innate responses, and immunization with ago-
nists for TLR7 (a sensor of single-stranded RNA), together with
alum or poly I:C, elicit broader neutralizing antibodies compared
to vaccines with alum adjuvant alone. However, these TLR7
agonist responses are no better than those from immunizations
with MF59 adjuvant. Deep sequencing of the antigen-specific B
cells is now being used to investigate the antibody repertoires
induced by the various strategies (Mastelic et al., 2013).
At the intersection of genetic influences on immunity and re-
sponses to vaccine adjuvants, genetic variants that alter innate
immune sensing pathways would be expected to alter vaccine
responses. The yellow fever vaccine, YF-17D, provides a long-
lived antibody response in part because of its potent stimulation
of pro-inflammatory cytokines via activation of TLRs 2, 7, 8, and
9 in multiple dendritic cell subsets (Querec et al., 2006). Human
TLR pathways have a variety of reported polymorphisms that
have been associated with susceptibility to various infections
and diseases (Netea et al., 2012) and genetic variations may
impact the effectiveness of the vaccine response. A recessive
variant of TIRAP, an adaptor molecule in the TLR2 and TLR4
pathways, has been linked to Hib vaccine response failure (Lad-
hani et al., 2010), while heterozygous variants have been demon-
strated to confer a protective effect against pneumococcal
disease, bacteremia, malaria, and tuberculosis among a cohort
totaling more than 6,000 individuals from Africa, the UK, and
Vietnam (Khor et al., 2007). The relationships between TLR
pathway variants and vaccine responses remain to be more fully
elucidated, but they appear to be an important source of inter-in-
dividual variation. As knowledge in this area grows, it may
become possible to improve vaccine formulations by including
adjuvants that show the most consistent effectiveness in hu-
mans of varying genetic backgrounds.
The importance of TLR signaling for effective immune re-
sponses has also raised questions of whether the body’s many
microbial populations contribute to vaccine responsiveness. A
recent paper addressing this topic in mice found that animals
lacking the TLR5 receptor for bacterial flagellin showed impaired
antibody responses to unadjuvanted influenza vaccines, and
that germ-free mice lacking microbes but expressing TLR5 had
similar poor responses (Oh et al., 2014). A simplified gut micro-
biome consisting of a flagellum-expressing strain E. coli, but
not a mutant strain lacking flagella, was able to restore antibody
responses to unadjuvanted influenza vaccination in the mice.
Notably, alum-adjuvanted vaccines for HIV envelope proteins
or yellow fever antigens were not dependent on the microbiome
flagellar signal (Oh et al., 2014). These initial observations sug-
gest that human microbiome variation may be an important
and previously overlooked variable in vaccine studies and may
help to explain variation in vaccination efficacy in individuals
who are treated with antibiotic drugs or other causes of micro-
biome perturbations.
Conclusions
Vaccine responses are clinically important but are also one of the
best windows into human immunology, because they introduceCell Host & Microbe 17, March 11, 2015 ª2015 Elsevier Inc. 305
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mental advances in human immunology in past decades have
defined major cell subsets, interactions, and functions contrib-
uting to effective immunity. Despite this progress, the goal of fully
understanding these complex cellular populations, and inte-
grating the effects of genetic variation between individuals, the
personal somatic genetics of antibody and TCR gene rearrange-
ments, as well as the individual’s life history of prior vaccinations,
infections, microbiomes, and other environmental exposures,
remains a tall order. Development of improved experimental
methods has accelerated in recent years but is not sufficient
by itself. Progress toward gathering data sets of sufficient quality
to permit predictive modeling of human immune responses will
likely require in-depth study of large, well-designed clinical co-
horts with a battery of tried and true immunological methods
as well as the new approaches outlined here. Rigorous data
analysis and the use of replication cohorts to validate results
from the new high-dimensional experimental methods will also
be essential to avoid the distractions of irreproducible results.
Of course, theremay also be a significant role for random chance
in the details of an individual’s vaccine response, as a particular
antibody lineage may only be stimulated if the correct B cell
encounters antigen at the right time and place, in the right envi-
ronment of T cell help and innate immune stimuli. Improved pre-
diction of human vaccine responses will likely have to take the
form of probabilistic statements based on data obtained with a
wide range of different assays. These are the challenges of un-
derstanding and predicting the behavior of a cellular system
selected by evolution to avoid being overly predictable to path-
ogens. We are optimistic that immunologists may fare better
than microbes in this task, but the years ahead will test this
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